Learn more about the faculty and staff at the Center for Translational Medicine by exploring the brief biographies provided below.
Dr. Gobburu is a world-renowned scientific leader in the area of quantitative disease models and their applications to decisions. He is best known for transforming the field of pharmacometrics into a decision-supporting science. His experience as a senior biomedical research scientist and Director of Pharmacometrics at the Food and Drug Administration (FDA) gives him unique insight into the technical, regulatory, and decision-making aspects in all phases of drug development. He obtained his BPharm and MSc in chemistry from the Birla Institute of Technology and Science, his PhD in pharmaceutical sciences from North Dakota State University, and his MBA from Johns Hopkins University.
Jeff coordinates the development of the Center for Translational Medicine by serving as a liaison between the Center's research team, the University's Center for Clinical Trials and Corporate Contracts, and industry clients. He assists with the tracking of business agreements and provides support for budget development, project analysis, and reporting for the parties involved with project execution. He returns to the University of Maryland after serving as a research manager at Johns Hopkins University. Previously, he worked as an epidemiologist with the University of Maryland Department of Epidemiology and Public Health and the Baltimore City Health Department.
Dr. Gopalakrishnan's main research interests include pharmacometrics, Bayesian applications in drug development, and innovative clinical trial designs. She obtained her bachelor's and master's degrees in pharmacy (BPharm and MPharm) from Birla Institute of Technology and Science in Pilani, India. She completed her master’s and doctorate in statistics from Department of Mathematics and Statistics at the University of Maryland, Baltimore County (UMBC).
Dr. Ivaturi's research focuses on the development of methods and tools for quantitative clinical pharmacology. He obtained his doctorate in experimental and clinical pharmacology from the University of Minnesota, which he followed with a post-doctoral fellowship in pharmacometrics at Uppsala University in Sweden.
Dr. Minocha's research focuses on leveraging PK/PD concepts to develop quantitative translational models for multiple sclerosis. He completed his doctorate in pharmacokinetics and drug delivery at the University of Missouri, Kansas City.
Devin's research focuses on utilizing quantitative models to support decision making through the drug development lifecycle. Devin completed his bachelor's degree in biochemistry at the University of North Carolina, Chapel Hill and his Master of Toxicology at North Carolina State University.
Peng served as project manager in the Office of Management and Communication at the Center for Drug Evaluation within China's Food and Drug Administration. He is a reviewer with eight years of drug evaluation experience in PK, BE, and CMC studies. He is familiar with drug R&D as well as relevant international regulations and guidance. Peng holds a master's degree in clinical pharmacokinetics from Peking Union Medical College Hospital.